---
{"dg-publish":true,"permalink":"/USMLE/Endocrine/Adrenal insufficiency/"}
---

# Epidemiology


---
# Etiology
## Primary adrenal insufficiency (Addison disease)
*   Destruction of the adrenal cortex leading to ↓ cortisol AND ↓ aldosterone.
*   **Most common cause in developed countries:** <span style="background:rgba(240, 200, 0, 0.2)">Autoimmune adrenalitis.</span>
*   Other causes: Infections ([[USMLE/Infective disease/Tuberculosis\|TB]], [[USMLE/Infective disease/Human immunodeficiency virus\|HIV]], fungal), <span style="background:rgba(240, 200, 0, 0.2)">bilateral adrenal hemorrhage ([[USMLE/Infective disease/Waterhouse-Friderichsen syndrome\|Waterhouse-Friderichsen syndrome]] in meningococcemia)</span>, metastasis.
## Secondary & tertiary adrenal insufficiency
*   **Secondary:** Decreased ACTH secretion from the pituitary (e.g., pituitary tumors, [[USMLE/Endocrine/Hypopituitarism\|Sheehan syndrome]]).
*   **Tertiary:** Decreased CRH from the [[USMLE/Neurology/Hypothalamus\|hypothalamus]]. **Most common cause:** Chronic exogenous steroid use followed by abrupt cessation.
*   <span style="background:rgba(240, 200, 0, 0.2)">Leads to ↓ cortisol ONLY. **Aldosterone is preserved** because it is primarily regulated by the Renin-Angiotensin-Aldosterone System (RAAS), not ACTH.</span>

| Feature | Primary AI | Secondary/Tertiary AI |
| :--- | :--- | :--- |
| **Defect** | Adrenal Gland Failure | ↓ ACTH / CRH (Pituitary/Hypothalamus) |
| **ACTH** | **↑ High** | **↓ Low** |
| **Aldosterone** | **↓ Low** | **Normal** (RAAS intact) |
| **Key Signs** | **Hyperpigmentation** & **Hyperkalemia** | **NO** hyperpigmentation or hyperkalemia |
| **Treatment** | Cortisol + Fludrocortisone | Cortisol **ONLY** |

---
# Pathophysiology
![Pasted image 20231208143231.png](/img/user/appendix/Pasted%20image%2020231208143231.png)

## Primary adrenal insufficiency (Addison disease)
Damage to the adrenal gland leads to the deficiency in all three hormones produced by the adrenal cortex: [[USMLE/Reproductive/Androgen and estrogen synthesis\|androgen]], cortisol, and aldosterone. 
- Hypoandrogenism 
	- Loss of libido
	- Impaired spermatogenesis (in men)
- Hypocortisolism leads to:
	- <span style="background:rgba(240, 200, 0, 0.2)">↑ ACTH</span> → ↑ production of POMC (in order to increase ACTH production) → ↑ melanocyte-stimulating hormone (MSH) → <span style="background:rgba(240, 200, 0, 0.2)">hyperpigmentation of the skin (bronze skin) </span>
	- <span style="background:rgba(240, 200, 0, 0.2)">↑ ADH level → retention of free water → dilutional [[USMLE/Neurology/Hyponatremia\|hyponatremia]]</span> 
	- <span style="background:rgba(240, 200, 0, 0.2)">↓ Expression of enzymes involved in [[USMLE/Biochemistry/Gluconeogenesis\|gluconeogenesis]] → ↓ rate of [[USMLE/Biochemistry/Gluconeogenesis\|gluconeogenesis]] → hypoglycemia</span>
	- Lack of potentiation of catecholamines action → hypotension
- Hypoaldosteronism → hypotension (hypotonic hyponatremia and volume contraction), hyperkalemia, metabolic acidosis
# Clinical features
---
## Hypocortisolism
- <span style="background:rgba(240, 200, 0, 0.2)">Weight loss</span>, anorexia
- Fatigue, lethargy, depression
- Muscle aches
- Weakness
- Gastrointestinal complaints (e.g., nausea, vomiting, [[USMLE/GI/Diarrhea\|diarrhea]])
- <span style="background:rgba(240, 200, 0, 0.2)">[[USMLE/Biochemistry/Permissive action\|Permissive action]]</span>
	- <span style="background:rgba(240, 200, 0, 0.2)">Sugar cravings</span>
	- <span style="background:rgba(240, 200, 0, 0.2)">(Orthostatic) hypotension</span>
		- Glucocorticoids play an important role in catecholamine‑induced vasoconstriction and myocardial contractility.
		- Think about 诱发三高和溃疡
### Lab findings
- <span style="background:rgba(240, 200, 0, 0.2)">[[USMLE/Endocrine/Hypoglycemia\|Hypoglycemia]] </span>
	- Glucocorticoids inhibit peripheral glucose utilization and increase [[USMLE/Biochemistry/Gluconeogenesis\|gluconeogenesis]].
- <span style="background:rgba(240, 200, 0, 0.2)">[[USMLE/Neurology/Hyponatremia\|Hyponatremia]]</span>
	- <span style="background:rgba(240, 200, 0, 0.2)">Glucocorticoids inhibit ADH secretion and thereby prevent excessive water retention. With adrenal insufficiency, ADH secretion is disinhibited causing increased reabsorption of free water with subsequent dilution [[USMLE/Neurology/Hyponatremia\|hyponatremia]].</span>
## Hypoaldosteronism 
- Hypotension
- Salt craving
### Lab findings
- [[USMLE/Neurology/Hyponatremia\|Hyponatremia]]
- [[USMLE/Cardiology/Hyperkalemia\|Hyperkalemia]]
- Normal anion gap metabolic acidosis
## <span style="background:rgba(240, 200, 0, 0.2)">Hypoandrogenism</span>
- Loss of libido
- <span style="background:rgba(240, 200, 0, 0.2)">Loss of axillary and pubic hair</span>
### Lab findings
- ↓ DHEA-S
## Elevated ACTH
- <span style="background:rgba(240, 200, 0, 0.2)">Hyperpigmentation of areas that are not normally exposed to sunlight (e.g., palmar creases, mucous membrane of the oral cavity)</span> → tanned skin![Pasted image 20231222100938.png](/img/user/appendix/Pasted%20image%2020231222100938.png)
	- caused by increased production of MSH (Melanocyte-Stimulating Hormone), which is cleaved from the same precursor peptide (POMC, Pro-opiomelanocortin) as ACTH.

---
# Diagnostics
- Overnight <span style="background:rgba(240, 200, 0, 0.2)">metyrapone stimulation test</span>
	- Physiological response: <span style="background:rgba(240, 200, 0, 0.2)">metyrapone inhibits 11β hydroxylase → impaired conversion of 11-deoxycortisol to cortisol (last step of cortisol synthesis) → ↓ serum cortisol → ↑ in CRH and plasma ACTH (negative feedback) → ↑ in adrenal steroidogenesis → ↑ in 11-deoxycortisol level</span>![L20059.jpg](/img/user/appendix/L20059.jpg)
	- In primary adrenal insufficiency: metyrapone → ↓ cortisol synthesis → ↑ in CRH/ACTH → <span style="background:rgba(240, 200, 0, 0.2)">no increase in adrenal steroid production → no increase in 11-deoxycortisol or cortisol levels</span>
	- In secondary/tertiary adrenal insufficiency: metyrapone → ↓ cortisol → no increase in CRH/ACTH → no increase in adrenal steroid production → no increase in 11-deoxycortisol or cortisol levels


# Treatment
---
## Steroid replacement
- Glucocorticoids
	- Hydrocortisone
	- Cortisone acetate
	- Prednisolone
- <span style="background:rgba(240, 200, 0, 0.2)">Mineralocorticoids</span> 
	- <span style="background:rgba(240, 200, 0, 0.2)">Agent: fludrocortisone (a synthetic mineralocorticoid with mostly mineralocorticoid and limited glucocorticoid effects)</span>

---
# Adrenal crisis
Adrenal crisis is an <span style="background:rgba(240, 200, 0, 0.2)">acute, severe [[USMLE/Pharmacology/Corticosteroids\|glucocorticoid]] deficiency that requires immediate emergency treatment.</span>
## Precipitating factors for adrenal crisis
- <span style="background:rgba(240, 200, 0, 0.2)">Stress in patients with underlying adrenal insufficiency</span> e.g.:
	- Gastrointestinal illness (most common)
	- Other infections
	- Perioperative period
- <span style="background:rgba(240, 200, 0, 0.2)">Sudden discontinuation of glucocorticoids</span> after prolonged [[USMLE/Pharmacology/Corticosteroids\|glucocorticoid]] therapy 
- Bilateral adrenal hemorrhage or infarction (e.g., [[USMLE/Infective disease/Waterhouse-Friderichsen syndrome\|Waterhouse-Friderichsen syndrome]])
- Pituitary apoplexy
>[!tip] 
>In order to prevent the development of secondary and tertiary adrenal insufficiency, prolonged steroid therapy should be tapered slowly rather than stopped abruptly.

## Signs and symptoms
- Hypotension, shock
- Impaired consciousness, coma
- Fever
- Vomiting, [[USMLE/GI/Diarrhea\|diarrhea]]
- Severe abdominal pain (which can resemble peritonitis)
# Autoimmune polyglandular syndromes
---
- Definition: a set of conditions characterized by autoimmune disease that causes multiple endocrine deficiencies, which affect the hormone-producing (endocrine) glands
- Types
	- Type 1: ([[USMLE/MSK/Antiphospholipid syndrome\|APS]]-1, Whitaker syndrome, autoimmune polyendocrinopathy-[[USMLE/Infective disease/Candidiasis\|candidiasis]]-ectodermal dystrophy, or APECED) 
		- <span style="background:rgba(240, 200, 0, 0.2)">Caused by a mutation in the autoimmune regulator gene (AIRE)</span>
			- Facilitates the elimination of self-reactive T cells.
		- Associated endocrine deficiencies (two or more of the following should be present)
			- Most commonly
				- <span style="background:rgba(240, 200, 0, 0.2)">Primary adrenal insufficiency</span>
				- <span style="background:rgba(240, 200, 0, 0.2)">Hypoparathyroidism</span>
				- <span style="background:rgba(240, 200, 0, 0.2)">Chronic mucocutaneous [[USMLE/Infective disease/Candidiasis\|candidiasis]]</span>
				- Ectodermal dystrophy of skin, nails, and dental enamel
	- Type 2 ([[USMLE/MSK/Antiphospholipid syndrome\|APS]]-2, Schmidt syndrome): defined by the occurrence of primary adrenal insufficiency with thyroid autoimmune disease and/or [[USMLE/Endocrine/Diabetes mellitus\|type 1 diabetes]] mellitus
		- Main manifestation: primary adrenal insufficiency
			- Associated endocrine deficiencies (one or more of the following may be present)
				- Most commonly
					- Thyroid autoimmune disease (e.g., [[USMLE/Endocrine/Hashimoto thyroiditis\|Hashimoto thyroiditis]])
					- [[USMLE/Endocrine/Diabetes mellitus\|Type 1 diabetes]] mellitus
